Novo Nordisk's semaglutide is rapidly gaining ground in India's anti-obesity market, challenging Eli Lilly's tirzepatide. Discover how...
pharma manufacturing
India is set to dominate the global homoeopathy market, driven by clinical expertise, strong practitioner networks, and...
Cipla USA recalls Nilotinib Capsules, a cancer drug, due to a manufacturing issue. The Class III recall...
The West Asia conflict fuels economic shifts: soaring private jet demand, potential shipping disruptions, and rising drug...
The Iran conflict threatens India's pharmaceutical exports, potentially costing $500 million. Increased freight costs and shipping disruptions...
Escalating Middle East conflict threatens India's pharma exports. Expect shipping delays, higher costs, and supply chain disruptions...
Glenmark Pharmaceuticals secures US FDA approval for its fluticasone propionate inhaler. This strategic move strengthens their respiratory...
Discover the story of ZYOG1, Zydus's pioneering oral GLP-1 agonist for diabetes and weight loss. Learn about...
AIIMS achieves a medical breakthrough! A young boy in India can hear again after a brain stem...
India's DengiAll vaccine is in final trials, offering a potential single-dose solution against dengue fever. Learn about...